11 nominees · 5 ballot items.
Election of 11 directors; advisory approval of named executive officers’ 2025 compensation (Say-on-Pay); approval of amendment and restatement to increase shares under 2021 Stock Incentive Plan; approval of Employee Stock Purchase Plan (1,000,000 shares); and ratification of KPMG LLP as independent auditors for 2026.
Elect 11 directors to serve until the next annual meeting and until their successors are duly elected and qualified.
Non-binding advisory vote to approve the compensation of the Company’s named executive officers for 2025, as disclosed in the Compensation Discussion and Analysis and compensation tables.
Approve an amendment to increase the number of shares available under the 2021 Stock Incentive Plan by 3,000,000 and make clarifying changes; restated plan attached as Appendix A.
The proposal asks shareholders to approve an amendment and restatement of the Company’s 2021 Stock Incentive Plan to add 3,000,000 shares to the plan’s share reserve and to make several technical and clarifying amendments (e.g., conforming references to Section 162(m), clarifying Section 409A applicability, and adding compliance and electronic delivery provisions). Management is pursuing shareholder approval because the Company has relied on equity awards—particularly performance-based restricted stock units—to attract, retain and incentivize employees and executives; with a limited remaining share reserve (3,097,839 shares available as of December 31, 2025) and an average historical annual grant rate of ~632,437 shares over the past five years, the plan could be exhausted without shareholder approval. The Board recommends a “FOR” vote, arguing equity awards are integral to competitive compensation, align employee and stockholder interests, and support long-term performance. The plan retains customary governance safeguards: per-participant annual limits (1,000,000 shares for performance awards; 100,000 for non-employee directors), prohibition on repricing without shareholder approval, and anti-dilution adjustments. The proposal has regulatory and accounting implications (e.g., Section 409A and Section 422 considerations for ISOs) and may be scrutinized by institutional investors concerned about dilution and pay-for-performance linkages; management counters by citing the Company’s strong performance metrics (ROA and ROE above peers, record loan and deposit growth) and the Compensation Committee’s compensation philosophy and performance metrics. If approved, the Company intends to register the additional shares on Form S-8. Key risks include potential dilution and the anti-takeover features (acceleration upon Change of Control) which some governance-focused investors might scrutinize.
Approve adoption of a Section 423-qualified Employee Stock Purchase Plan with an initial reserve of 1,000,000 shares, 90% exercise price, six-month offering periods, and eligibility and per-employee limits per the plan.
This management proposal requests shareholder approval to adopt a new Section 423-qualified Employee Stock Purchase Plan with a 1,000,000 share reserve, six-month offering periods (commencing around April 1 and October 1), a 90% exercise price (i.e., 10% discount at exercise date), and employee contribution limits (1%–25% of pay) subject to the statutory $25,000 annual accrual limit. The plan is designed to broaden employee ownership and aid recruitment and retention, and the Board recommends a “FOR” vote emphasizing alignment of employee and shareholder interests. The plan has standard Section 423 protections and administrative provisions, including pro rata allocations if shares run out, eligibility limitations, and customary tax and withholding mechanics. Investors will evaluate the ESPP for dilution (1,000,000 shares initial reserve) and whether its design encourages participation across the workforce; management argues the program supports retention and engagement. The Company will register the shares on Form S-8 if the ESPP is approved, and the Administrator (Compensation Committee) has discretion to adopt subplans or local terms for participants outside the U.S.
Ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | 5.7% | 7,858,792 | $839M |
| 2 | VANGUARD PORTFOLIO MANAGEMENT LLC | 4.9% | 6,723,507 | $718M |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 4.5% | 6,163,753 | $658M |
| 4 | FMR LLC | 4.2% | 5,700,019 | $609M |
| 5 | Invesco Ltd. | 3.9% | 5,298,057 | $566M |
| 6 | STATE STREET CORP | 3.6% | 4,964,533 | $530M |
| 7 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 3.0% | 4,049,835 | $432M |
| 8 | BlackRock, Inc. | 3.0% | 4,044,783 | $432M |
| 9 | FIRST TRUST ADVISORS LP | 2.9% | 3,918,515 | $418M |
| 10 | SCHRODER INVESTMENT MANAGEMENT GROUP | 2.2% | 3,036,123 | $315M |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.